1. Home
  2. FFWM vs CTMX Comparison

FFWM vs CTMX Comparison

Compare FFWM & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Foundation Inc.

FFWM

First Foundation Inc.

N/A

Current Price

$5.77

Market Cap

518.9M

Sector

Finance

ML Signal

N/A

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

N/A

Current Price

$5.02

Market Cap

596.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FFWM
CTMX
Founded
1990
2008
Country
United States
United States
Employees
485
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
518.9M
596.2M
IPO Year
2014
2015

Fundamental Metrics

Financial Performance
Metric
FFWM
CTMX
Price
$5.77
$5.02
Analyst Decision
Buy
Strong Buy
Analyst Count
3
7
Target Price
$6.17
$8.86
AVG Volume (30 Days)
635.6K
2.6M
Earning Date
04-29-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$36,229,000.00
$138,103,000.00
Revenue This Year
$56.34
N/A
Revenue Next Year
$10.68
N/A
P/E Ratio
N/A
$22.58
Revenue Growth
2.71
36.45
52 Week Low
$4.42
$0.40
52 Week High
$6.72
$6.35

Technical Indicators

Market Signals
Indicator
FFWM
CTMX
Relative Strength Index (RSI) 39.05 46.26
Support Level $5.03 $3.83
Resistance Level $5.95 $6.20
Average True Range (ATR) 0.24 0.33
MACD -0.04 -0.10
Stochastic Oscillator 17.86 28.11

Price Performance

Historical Comparison
FFWM
CTMX

About FFWM First Foundation Inc.

First Foundation Inc is a financial services company. It is engaged in providing investment management and financial planning services for high-net-worth individuals, retirement plans, charitable institutions, and private foundations. The company focuses on segments namely Banking and Wealth Management. It also offers loans to individuals and entities that own and operate multifamily residential and commercial real estate properties as well as business banking products and services to small to moderate-sized businesses, professional firms, and consumer banking products and services to individuals.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: